26
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2431 |
ID-8
ID8 |
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
ID-8 是 DYRK 抑制剂,长时间培养能够维持胚胎干细胞的自我更新。 | |||
T6257 |
AZ191
|
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
AZ191 是特异性 DYRK1B 抑制剂。它对 DYRK1B 的特异性分别是 DYRK1A 和 DYRK2 的 5 倍和 110 倍。 | |||
TQ0111 |
LDN-192960
|
DYRK; Haspin Kinase | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
LDN-192960 是 Haspin 和 DYRK2 的有效抑制剂(IC50:10 nM 和 48 nM)。 | |||
T15422 |
GSK-626616
|
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
GSK-626616 是一种口服具有活力的 DYRK3抑制剂 (IC50:0.7 nM)。它以相似的效力抑制 DYRK 家族的其他成员,可用于研究贫血。 | |||
T14980 |
CLK-IN-T3
|
DYRK; CDK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
CLK-IN-T3 是 CLK1、CLK2 和 CLK3 的抑制剂,IC50 为 0.67、15 和 110 nM。 CLK-IN-T3 具有抗癌活性。 | |||
T40187 |
GNF2133
|
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
GNF2133 是一种有效的特异性 DYRK1A 抑制剂,IC50 为 6.2 nM。 GNF2133 可用于关于 1 型糖尿病的研究。 | |||
T11447 |
GNF4877
|
GSK-3; DYRK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
GNF4877 是一种 DYRK1A (IC50:6 nM) 和 GSK3β (IC50:16 nM) 抑制剂。 它导致激活 T 细胞核因子核输出的阻断和 β 细胞增殖细胞增加。 | |||
T7323 |
BCI-215
|
Phosphatase | Metabolism |
BCI-215 是高效肿瘤细胞选择性的双重特异性磷酸酶DUSP-MKP 抑制剂。它对肿瘤细胞有细胞毒性,但对正常细胞无毒性。 | |||
T14364 |
AZ-Dyrk1B-33
3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine |
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) 是高选择性的Dyrk1B 激酶抑制剂,其IC50=7 nM。 | |||
T4636 |
Protein kinase inhibitors 1
|
Others; DYRK | Cell Cycle/Checkpoint; Others; Tyrosine Kinase/Adaptors |
Protein kinase inhibitors 1 是新型的 HIPK2 抑制剂,其 IC50=74 nM,Kd=9.5 nM。 | |||
T4308 |
F1063-0967
|
Phosphatase | Metabolism |
F1063-0967 是双特异性磷酸酶 26 抑制剂,其IC50=11.62 μM。 | |||
T16357 |
DA-3003-1
NSC 663284 |
Phosphatase | Metabolism |
DA-3003-1 (DA-3003-1) 是一种可渗透进细胞膜且具有有效性和选择性的 Cdc25 dual specificity phosphatase 抑制剂,具有抗肿瘤活性,对 Cdc25B2、Cdc25A、Cdc25B2 和 Cdc25C具有抑制作用。 | |||
T12263L |
NSC305787 hydrochloride
(Rac)-NSC305787 hydrochloride |
Others | Others |
NSC305787 hydrochloride ((Rac)-NSC305787 hydrochloride) 是一种可透过细胞膜且具有选择性和有效性的小分子 Cdc25 dual specificity phosphatase 和 EZR 双重抑制剂,在胰腺癌细胞中显示出抗肿瘤活性,对Cdc25B2, Cdc25A,Cdc25B2 和 Cdc25C 具有抑制作用。NSC 663284 抑制 NSD2 (IC50 of 170 nM) 酶的活性。 | |||
T16350 |
NSC-87877
|
Apoptosis; Phosphatase | Apoptosis; Metabolism |
NSC-87877 是一种Shp2和Shp1蛋白质酪氨酸磷酸酶抑制剂,IC50值分别为0.318 μM 和0.355 μM。它还抑制双特异性磷酸酶26。 | |||
T10486 |
BCI
(E)-BCI |
Phosphatase | Metabolism |
BCI ((E)-BCI) 是双重特异性磷酸酶的变构抑制剂。它特异性抑制 DUSP6和 DUSP1的 EC50分别为 13.3 和 8.0 μM,但不能够抑制 DUSP5。 | |||
T7078 |
NSC 95397
|
Apoptosis; Phosphatase | Apoptosis; Metabolism |
NSC 95397 是一种选择性的Cdc25双特异性磷酸酶抑制剂。它抑制丝裂原活化蛋白激酶磷酸酶-1(MKP-1),通过 MKP-1 和 ERK1/2 途径抑制结肠癌细胞的增殖并诱导细胞凋亡。 | |||
T2381 |
Abemaciclib
CDK4/6 dual inhibitor,LY2835219 |
CDK | Cell Cycle/Checkpoint |
Abemaciclib (LY2835219) 是一种 CDK4/6 的双重抑制剂 (IC50=2/10 nM),具有选择性和特异性。Abemaciclib 具有抗肿瘤活性,被用于治疗晚期或转移性乳腺癌。 | |||
T11139 |
(E/Z)-BCI
NSC 150117 |
Apoptosis; Phosphatase | Apoptosis; Metabolism |
(E/Z)-BCI (NSC-150117) 是一种DUSP6抑制剂,可通过激活 Nrf2 信号和抑制 NF-κB 通路,减弱 LPS 诱导的巨噬细胞炎症和 ROS 生成,具有抗炎活性。 | |||
T11830 |
LDN-192960 hydrochloride
|
Others | Others |
LDN-192960 hydrochloride is an inhibitor of Dual-specificity Tyrosine-regulated Kinase 2 (DYRK2) and Haspin with IC50s of 48 nM and 10 nM, respectively. | |||
T11132 | DYRKs-IN-1 | DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively. | |||
T10486L |
BCI hydrochloride
(E)-BCI hydrochloride |
Others | Others |
BCI hydrochloride specifically inhibits DUSP6 and DUSP1 with EC50s of 13.3 and 8.0 μM in cells, respectively. BCI hydrochloride does not inhibit DUSP5. BCI hydrochloride is an allosteric inhibitor of dual specificity phosphatase (DUSP). | |||
T40968 |
MLS-0437605
|
||
MLS-0437605 is a potent and selective inhibitor of dual-specificity phosphatase 3 (DUSP3), with an IC50 of 3.7 μM. It exhibits higher selectivity towards DUSP3 in comparison to DUSP22 and other protein tyrosine phosphatases (PTPs). | |||
T72242 |
DYRKs-IN-1 hydrochloride
|
||
DYRKs-IN-1 hydrochloride是一种有效的DYRKs(双特异性酪氨酸磷酸化调节激酶)抑制剂,对DYRK1A和DYRK1B的IC50分别为5 nM和8 nM,具有抗肿瘤活性。 | |||
T69826 |
U-0126
|
||
U0126 is a highly selective inhibitor of both MEK1 and MEK2, a type of MAPK/ERK kinase. It was found to functionally antagonize AP-1 transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with IC50 of 72 nM for MEK1 and 58 nM for MEK2. U0126 inhibited anchorage-independent growth of Ki-ras-transformed rat fibroblasts by simultaneously blocking both extracellular signal-regulated kinase and mammalian target of rapamycin pathways. | |||
T71163 |
Pimasertib HCl
|
||
Pimasertib HCl is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. Pimasertib selectively binds to and inhibits the activity of MEK1/2, preventing the activation of MEK1/2-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK1/2 (MAP2K1/K2) are dual-specificity threonine/tyrosine kinases that play key roles in the activati... | |||
T60824 | Dyrk1A-IN-3 | ||
Dyrk1A-IN-3 (Compound 8b) 是双特异性酪氨酸调节激酶 1A (DYRK1A) 的高选择性抑制剂。Dyrk1A-IN-3与 DYRK1A 结合具有高结合亲和力,IC50值为76 nM。Dyrk1A-IN-3可用于研究神经退行性疾病,例如,阿尔茨海默病、亨廷顿病和帕金森病等。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1711 |
Harmine
Telepathine,去氢骆驼蓬碱 |
MAO; 5-HT Receptor; DYRK | Cell Cycle/Checkpoint; GPCR/G Protein; Metabolism; Neuroscience; Tyrosine Kinase/Adaptors |
Harmine (Telepathine) 是一种从山茱萸种子中分离出来的生物碱,具有抗癌和抗炎活性。它是双特异性酪氨酸磷酸化调节激酶抑制剂,对5-HT2A 血清素受体具有高亲和力,Ki 值为 397 nM。 | |||
T2811 |
Harmine hydrochloride
telepathine hydrochloride,盐酸哈尔明碱 |
5-HT Receptor; DYRK; GluR | Cell Cycle/Checkpoint; GPCR/G Protein; Neuroscience; Tyrosine Kinase/Adaptors |
Harmine hydrochloride (telepathine hydrochloride) 是一种 DYRK 抑制剂,具有抗癌和抗炎活性。它对5-HT2A 血清素受体具有高亲和力,Ki 值为 397 nM。 | |||
T10238 |
Aclacinomycin A hydrochloride
盐酸阿柔比星,Aclarubicin hydrochloride |
Proteasome | Proteases/Proteasome; Ubiquitination |
Aclacinomycin A (Aclarubicin) hydrochloride is a fluorescent molecule and the first described non-peptidic inhibitor showing discrete specificity for the CTRL (chymotrypsin-like) activity of the 20S proteasome. Aclacinomycin A hydrochloride is also a dual inhibitor of topoisomerase I and II. |